OBJECTIVES The goal of this study was to evaluate the diagnostic performance of a comprehensive, multicomponent cardiac magnetic resonance (CMR) study for assessment of left atrial (LA) and left atrial appendage (LAA) thrombus.
atrial contractile function are the major underlying pathophysiology of thromboembolism in patients with AF (3).
Pulmonary vein isolation (PVI) has evolved
as an effective therapeutic option for patients with AF (1, 4) . As a part of the pre-operative preparation, cardiac computed tomography (CT) or cardiac magnetic resonance (CMR) imaging is usually performed to provide a precise map of the pulmonary venous anatomy (4) . In addition, transesophageal echocardiography (TEE) is frequently performed before PVI to exclude the presence of left atrial (LA) or LAA thrombus (4) . TEE is currently considered the gold standard for LA/LAA thrombus detection given its favorable sensitivity and specificity (1, (4) (5) (6) . With recent advances, cardiac CT scanning is now becoming another reliable diagnostic method for evaluation of thrombus in the left atrium and LAA, particularly when delayed imaging is performed (6) . However, it exposes patients to increased radiation doses and a potential risk of contrast-induced nephropathy (6, 7) .
CMR is a useful imaging technique that can provide valuable information in multiple clinical scenarios such as assessment of myocardial viability, valvular function, and evaluation of the vascular system (via magnetic resonance angiography [MRA] or venography) (8) . Effectiveness of left ventricular thrombus detection by CMR has been validated, and it is now becoming a preferred imaging modality for evaluation of left ventricular thrombus (8) (9) (10) . To our knowledge, there are few data regarding the utility of CMR for detection of LA/LAA thrombus (11) (12) (13) . The goal of the present study was to systematically evaluate the diagnostic performance of a comprehensive multicomponent CMR assessment for detection of LA/LAA thrombus in patients referred for PVI. Images refer to subject #4 in Table 2 . LA ¼ left atrium; LV ¼ left ventricle.
Kitkungvan et al. 
RESULTS
During the study period, 261 multicomponent CMR studies met the inclusion criteria and were included for further analysis. The patient baseline characteristics are summarized in Kitkungvan et al.
continued on therapeutic anticoagulation throughout the pre-procedural period until the day of the PVI procedure.
CMR findings are shown in Table 1 There were no complications from TEE or CMR noted for the study patients. According to TEE, LA and LAA thrombi were detected in 9 studies (3.5%)
as shown in 
AE
Normal values for LVEF and LA volume index as detailed in Table 1 . *Thrombus size was measured from its largest dimension by using TEE and long TI DE-CMR. †Unlike in subjects #1 through #9, thrombus was not detected by TEE in subjects #10 and #11, resulting in a false-positive interpretation by long TI DE-CMR. Table 1 .
Kitkungvan et al. Contrast-enhanced MRA was not able to identify this mural thrombus. Images refer to subject #2 in Table 2 . Abbreviations as in Figure 1 . whereas (C) contrast-enhanced MRA failed to identify LAA thrombus. Images refer to subject #9 in Table 2 . Abbreviations as in Figure 1 .
advantages over other CMR components in multiple ways. It is known that prevalence can affect diagnostic performance of a test and therefore the performance characteristics of the CMR components in our study needs to be interpreted with this fact in mind.
However, multiple studies using cardiac CT scanning to evaluate LA/LAA thrombus with TEE as the reference standard in the setting of PVI demonstrated an incidence/prevalence of LA/LAA thrombus of 2% to 19% (6), which appears in line with our data, thus supporting the generalizability of our findings.
Despite being the largest study to evaluate the diagnostic performance of CMR in assessing LA/LAA thrombus, the results of our study reflect the experience from a single center. Further multicenter studies with larger sample sizes are necessary to confirm our findings.
CONCLUSIONS
In patients referred for PVI, CMR is a noninvasive test that has a favorable diagnostic performance and could be an alternative imaging modality to TEE for assessment of LA/LAA thrombus. In our study, long TI DE-CMR was shown to be the most reliable CMR 
